Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 825 shares at $293.15 ($242K) on 2022-08-08, disclosed to the SEC on 2022-08-10.
Open-market sale of $242k VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.18 | 45 | $13K | 5.4% |
| 2 | $291.76 | 164 | $48K | 19.8% |
| 3 | $293.15 | 204 | $60K | 24.7% |
| 4 | $293.15 | 204 | $60K | 24.7% |
| 5 | $294.24 | 161 | $47K | 19.6% |
| 6 | $295.53 | 47 |
| $14K |
| 5.7% |
| Total | $293.06 avg | 825 | $242K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |